See All Slides - tctmd.com

Slides

Presentation TCT 2014

24h Ambulatory Blood Pressure (ABPM) Change After Using The New Symplicity Spyral Renal Sympathetic Denervation Device In Patients With Resistant Hypertension ? First Results Fr___

Presenter: Alexander Plehn

September 16, 2014

Presentation TCT 2014

Comparison between of Mitral Balloon Valvuloplasty and Surgical Commissurotomy for Mitral Valve Stenosis: Meta-Analysis of the Randomized Clinical Trials

Presenter: Daniel Garcia

September 16, 2014

Presentation TCT 2014

Outcomes Following Percutaneous Reduction of Significant Mitral Regurgitation in EVEREST II High Risk Patients Who Were Symptomatic Despite Cardiac Resynchronization Therapy

Presenter: Saibal Kar

September 16, 2014

Presentation TCT 2014

Comparison of endothelialization and inflammation between thin- and thick-strut contemporary bioerodable polymer drug-eluting stents and thick-strut fully resorbable scaffolds i___

Presenter: Kazuyuki Yahagi

September 16, 2014

Presentation TCT 2014

N-terminal Pro-B-type Natriuretic Peptide Ratio Predicts Mortality After Transcatheter Aortic Valve Replacement

Presenter: Ronald Binder

September 16, 2014

Presentation TCT 2014

ABSORB Cohort B Trial: Five Year Angiographic Results Of The ABSORB Everolimus Eluting Bioresorbable Vascular Scaffold_

Presenter: Bernard De Bruyne

September 16, 2014

Presentation TCT 2014

Two-Year Clinical Outcome of Patients With Implantation of Second-Generation Drug-Eluting Stents in the Right Coronary Ostium in the TWENTE Trial

Presenter: Ming Kai Lam

September 16, 2014

Presentation TCT 2014

Tissue Removal Assessment with Ultrasound of the SFA and Popliteal Study (TRUTH): Orbital Atherectomy Acute Data and Intravascular Ultrasound Analysis

Presenter: Anvar Babaev

September 16, 2014

Presentation TCT 2014

Utility of Fractional Flow Reserve Assessment in Aortic Stenosis

Presenter: Edward Coverstone

September 16, 2014

Presentation TCT 2014

Carotid Artery Stenting with Double Cerebral Embolic Protection in Symptomatic Patients

Presenter: Ferdinando Varbella

September 16, 2014

Advertisement

Slides

24h Ambulatory Blood Pressure (ABPM) Change After Using The New Symplicity Spyral Renal Sympathetic Denervation Device In Patients With Resistant Hypertension ? First Results Fr___

Comparison between of Mitral Balloon Valvuloplasty and Surgical Commissurotomy for Mitral Valve Stenosis: Meta-Analysis of the Randomized Clinical Trials

Outcomes Following Percutaneous Reduction of Significant Mitral Regurgitation in EVEREST II High Risk Patients Who Were Symptomatic Despite Cardiac Resynchronization Therapy

Comparison of endothelialization and inflammation between thin- and thick-strut contemporary bioerodable polymer drug-eluting stents and thick-strut fully resorbable scaffolds i___

N-terminal Pro-B-type Natriuretic Peptide Ratio Predicts Mortality After Transcatheter Aortic Valve Replacement

ABSORB Cohort B Trial: Five Year Angiographic Results Of The ABSORB Everolimus Eluting Bioresorbable Vascular Scaffold_

Two-Year Clinical Outcome of Patients With Implantation of Second-Generation Drug-Eluting Stents in the Right Coronary Ostium in the TWENTE Trial

Tissue Removal Assessment with Ultrasound of the SFA and Popliteal Study (TRUTH): Orbital Atherectomy Acute Data and Intravascular Ultrasound Analysis

Utility of Fractional Flow Reserve Assessment in Aortic Stenosis

Carotid Artery Stenting with Double Cerebral Embolic Protection in Symptomatic Patients

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content